Skip to content

Automated Detection of Brain Metastases on MRI

Validation of an AI Software for Detection of Brain Metastases on MRI: AIDED Versus UNAIDED Performance

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06727032
Acronym
BrainMets AI
Enrollment
12
Registered
2024-12-10
Start date
2025-01-24
Completion date
2025-10-31
Last updated
2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Metastases

Brief summary

This reader study aims at assessing whether the radiologist aided with AI software has at least a non-inferior performance than without AI assistance in detecting brain metastases. 200 retrospective MRI images will be included in the study with 100 positive and 100 negative exams. Assessment will be completed by 12 readers with varying level of experience. This is a Retrospective Multiple-Reader Multiple-Case (MRMC) randomised study.

Interventions

DEVICEBrain Metastasis AI

There will be no intervention

Sponsors

Netherlands Cancer Institute - NKI
CollaboratorUNKNOWN
Robovision BV
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* subjects older than 18 years with a known or possible primary extracranial cancer who undergo MRI for diagnosis, treatment planning or follow-up of brain metastases.

Exclusion criteria

* subjects with primary intracranial tumor(s), with more than 10 brain metastases, with meningeal metastases, with radiation necrosis, or post brain surgery

Design outcomes

Primary

MeasureTime frameDescription
Detection accuracy3 monthsDemonstrate that the accuracy for detecting brain metastases by radiologists on MRI using the software (AIDED) is at least non-inferior to that of radiologists not using the software (UNAIDED).

Secondary

MeasureTime frameDescription
Reading time3 monthsDemonstrate that the AIDED radiologists reading time for detecting brain metastases is significantly lower than for UNAIDED radiologists.
Inter-reader agreement3 monthsDemonstrate that AIDED reading reduces detection variation between observers/readers in brain metastasis detection.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026